Noevir Holdings Co., Ltd.

4928

JP3760450001

Personal Products

Delayed Japan Exchange Other stock markets 01:30:00 2024-12-02 am EST			5-day change	1st Jan Change
4,925.00 ^JPY	-0.10%		-0.81%	-4.18%

Nov. 08	Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2025	CI
2023	Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024	CI

Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2025

November 08, 2024 at 01:30 am EST

Noevir Holdings Co., Ltd. provided consolidated earnings guidance for the fiscal year ending September 30, 2025. For the year, the company expects net sales to be JPY 64,000 million, operating profit to be JPY 11,500 million, profit attributable to owners of parent to be JPY 8,000 million and Basic earnings per share to be JPY 234.22.

Latest news about Noevir Holdings Co., Ltd.

Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2025	Nov. 08	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024	Nov. 07	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024	23-08-07	CI
Noevir Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023	23-05-10	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023	23-05-10	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023	23-02-07	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023	22-11-10	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022	22-08-04	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022	22-05-11	CI
Noevir Holdings Co., Ltd. Provides Earnings Guidance for the Six Months Ending March 2022 and for the Year Ending September 2022	22-02-08	CI
FACTBOX-Japanese companies opening COVID-19 vaccination sites amid slow national rollout	21-06-04	RE
An unknown buyer acquired a 12.9% stake in Noevir Holdings Co., Ltd. from Takashi Okura.	20-08-02	CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending September 30, 2019	19-08-13	CI
Noevir Holdings Co., Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2018; Provides Earnings Forecast for the Half Year of the Fiscal Year Ending Sept. 30, 2019; Provides Earnings Forecast for the Full Year of the Fiscal Year Ending Sept. 30, 2019; Provides Dividend Forecast for the Fourth Quarter of Fiscal Year Ending Sept. 30, 2019	19-02-11	CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Year Ended September 30, 2018; Provides Earnings Guidance for the Half Year and Year Ending September 30, 2019	18-11-19	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2018; Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2018	18-08-12	CI
Noevir Holdings Co., Ltd.(TSE:4928) added to FTSE All-World Index	18-03-19	CI
Noevir Holdings Co., Ltd.(TSE:4928) added to FTSE All-World Index	18-03-19	CI
Noevir Holdings Co., Ltd. Announces Unaudited Earnings Results for the Three Months Ended December 31, 2017; Provides Earnings Guidance for the Half Year and Full Year for the Fiscal Year Ended September 30, 2018	18-01-31	CI
Tranche Update on Noevir Holdings Co., Ltd.'s Equity Buyback Plan announced on November 7, 2017.	17-11-08	CI
Noevir Holdings Co., Ltd.'s Equity Buyback announced on November 7, 2017 has expired with 1,295,000 shares for ¥9,971.5 million.	17-11-08	CI
Noevir Holdings Co., Ltd. announces an Equity Buyback for 1,500,000 shares, representing 4.23% for ¥11,000 million.	17-11-07	CI
Noevir Holdings Co., Ltd. authorizes a Buyback Plan.	17-11-06	CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Full Year Ended September 30, 2017; Provides Consolidated Earnings Guidance for the First Half and Full Year Ending September 30, 2018; Announces Year-End Dividend for the Year Ended September 30, 2017, Payable on December 8, 2017; Provides Dividend Guidance for the Year Ending September 30, 2018	17-11-06	CI
Noevir Holdings Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending September 30, 2017	17-07-31	CI

Chart Noevir Holdings Co., Ltd.

Duration

Period

4928: Dynamic Chart

Company Profile

Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.

Employees

1,368

Sector

Personal Products

Calendar

2025-02-10 - Q1 2025 Earnings Release (Projected)

More about the company